SLS (STOCKS)
SELLAS Life Sciences Group, Inc. Common Stock
$4.720500
-0.039500 (-0.83%)
Prev close: $4.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Angelos M. Stergiou
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $854.82M
- Employees
- 15
- P/E (TTM)
- -19.36
- P/B (TTM)
- 10.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.05 | $-0.07 | +0.0157 | +23.90% |
|
Sep 2025 (Q3)
|
$-0.06 | $-0.07 | +0.0067 | +10.05% |
|
Jun 2025 (Q2)
|
$-0.07 | $-0.08 | +0.0132 | +15.87% |
|
Mar 2025 (Q1)
|
$-0.07 | $-0.11 | +0.0361 | +34.02% |
Financial Statements
| Revenues | $0.00 |
| Cost Of Revenue | $0.00 |
| Costs And Expenses | $28.27M |
| Nonoperating Income/Loss | $1.41M |
| Selling, General, and Administrative Expenses | $12.25M |
| Operating Income/Loss | -$28.27M |
| Income/Loss From Continuing Operations After Tax | -$26.86M |
| Income/Loss From Continuing Operations Before Tax | -$26.86M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$26.86M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$26.86M |
| Net Income/Loss Available To Common Stockholders, Basic | -$26.86M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.25 |
| Diluted Earnings Per Share | -$0.25 |
| Basic Average Shares | 109,051,215 |
| Diluted Average Shares | 109,051,215 |
| Assets | $78.35M |
| Current Assets | $75.21M |
| Noncurrent Assets | $3.13M |
| Liabilities | $7.47M |
| Current Liabilities | $7.02M |
| Accounts Payable | $2.95M |
| Wages | $1.75M |
| Other Current Liabilities | $2.32M |
| Noncurrent Liabilities | $457.00K |
| Equity | $70.87M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $70.87M |
| Liabilities And Equity | $78.35M |
| Net Cash Flow From Operating Activities | -$28.39M |
| Net Cash Flow From Operating Activities, Continuing | -$28.39M |
| Net Cash Flow From Investing Activities | -$57.91M |
| Net Cash Flow From Investing Activities, Continuing | -$57.91M |
| Net Cash Flow From Financing Activities | $86.30M |
| Net Cash Flow From Financing Activities, Continuing | $86.30M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$26.86M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$26.86M |
| Other Comprehensive Income/Loss | $0.00 |